GAE for Knee Osteoarthritis Pain
Genicular artery embolization is a minimally invasive procedure intended to reduce selected abnormal blood flow associated with an inflamed knee lining. It does not regrow cartilage or cure osteoarthritis—and sham-controlled studies have reported mixed results.
In short: Genicular artery embolization (GAE) is a non-surgical, outpatient procedure for knee osteoarthritis pain that reduces abnormal blood flow to the inflamed joint lining. It suits adults with mild-to-moderate arthritis whose pain persists despite physical therapy, medication or injections; it does not repair cartilage, and sham-controlled trials show mixed results. At SoCal Interventional, Dr. Nathanael Sabbah evaluates patients for GAE at offices in Van Nuys, Tarzana and Fountain Valley.
Knee osteoarthritis affects cartilage, bone, and the joint lining. In some painful knees, synovial inflammation is associated with increased small-vessel blood flow. GAE uses angiography to identify selected genicular branches and deliver microscopic particles with the goal of reducing that hypervascularity.
If cortisone injections have stopped helping, read what GAE can and cannot do after cortisone stops working.
To see whether your knee matches the patients studied, read who is a candidate for genicular artery embolization.
GAE candidates are typically adults aged 45 to 80 with knee osteoarthritis graded mild to moderate (Kellgren–Lawrence 1–3) on X-ray, pain for six months or more despite physical therapy, medication or injections, and no active infection, bleeding disorder or severe arterial disease. Bone-on-bone arthritis, instability or a locking meniscal tear usually points to orthopedic surgery instead.
GAE is offered to patients who look like the people in the published trials. The checklist below is the starting point; a consultation with X-ray review confirms it.
GAE is an outpatient procedure done under local anesthetic and light sedation through a small puncture in the groin or lower leg. Angiography maps the genicular arteries, microspheres are injected only into the branches feeding the inflamed lining, and most patients go home the same day after one to two hours of observation, about three hours on site.
What happens from the first visit to the six-month follow-up.
Knee X-ray within 12 months; MRI if available. Insurance verification the same week.
Outpatient, local anesthetic and light sedation; access through a small puncture in the groin or the foot/ankle side of the leg.
Maps the six genicular arteries; the branches feeding the inflamed lining show a characteristic “blush”.
Microspheres (100–300 µm) are injected into only those branches until the abnormal flow stops; the normal arteries to skin and bone are protected.
1–2 hours of observation; home the same day with a driver. Total time on site about 3 hours.
Call at 1 week, visit or telehealth at 6 weeks and 6 months; outcome tracked with KOOS pain and function scores.
GAE sits between injections and surgery. Cortisone and gel injections are simpler but usually wear off within weeks to months; knee replacement treats advanced structural arthritis definitively but is major surgery with a longer recovery. GAE is a single outpatient procedure that does not remove the option of replacement later, though it cannot guarantee that surgery will be avoided.
Recovery is short: most people walk the same day and return to desk work within one to two days, with puncture-site tenderness for a few days and, in about one in ten, temporary skin discoloration over the knee that fades on its own. Pain relief typically begins within two to six weeks. Serious complications are rare.
GAE has one long-term single-arm series, several sham-controlled randomized trials and two large comparative trials under way. The single-arm data are consistently positive; the sham-controlled data are mixed. Both facts belong on the page.
| Study | Design | Patients | Key result | Safety |
|---|---|---|---|---|
| GENESIS long-term (CVIR 2024) | Single-arm, permanent microspheres, UK | 46 treated, 40 followed; mean 17.3 months | VAS pain 58.6 → 37.7 at 2 years; MCID reached at 2 years by 57% (pain), 61% (daily living), 64% (symptoms), 64% (quality of life) | Transient skin discoloration 10%; 1 groin hematoma; 1 DVT; no osteonecrosis |
| Systematic review of sham-controlled RCTs (2025) | 3 RCTs vs sham | 138 | Mixed: one trial −50.8 vs −0.5 VAS at 1 month; another only a 3-point KOOS difference (not significant); benefit clearer when embolization was technically complete | No serious adverse events; minor, self-limited |
| 2023 triple-blind RCT | GAE vs sham | — | No overall difference at 12 months; possible benefit in complete embolizations | — |
| 2024 sham-controlled RCT | GAE vs sham | — | Similar pain reduction at 4 months; more mild adverse events in the GAE arm | — |
| 2025 single-arm study | Prospective | 25 | 62% clinical success at 12 months | No severe adverse events |
| MOTION (NCT05818150) | Multicenter RCT, GAE vs corticosteroid injection | Enrolling | Results pending | — |
| GAUCHO (Brazil) | RCT, imipenem/cilastatin vs 100–300 µm microspheres | 60 | 12-month follow-up reported; ≈60% one-year clinical success quoted by investigators | Skin discoloration common and transient |
What this means for a patient: GAE reliably reduces abnormal blood flow in the inflamed knee lining and most treated patients in open-label series report meaningful relief that lasts a year or more; the blinded trials show that part of that relief overlaps with the placebo response, and that technique matters. Dr. Sabbah’s position: offer GAE to patients who match the trial populations, say plainly that it is not cartilage repair, and keep joint replacement available later.
Research continues to evolve. Educational information only.
Dr. Nathanael Sabbah, an interventional radiologist, performs GAE for patients from Los Angeles, the San Fernando Valley (Van Nuys, Tarzana, Encino, Sherman Oaks, Woodland Hills) and Orange County (Fountain Valley, Huntington Beach, Irvine, Newport Beach) at SoCal Interventional. Call (310) 929-0026 to confirm the nearest office and book an evaluation.
SoCal Interventional evaluates selected patients with imaging-confirmed knee osteoarthritis in Fountain Valley (10900 Warner Ave, Suite 101A) for Orange County, and at offices in Van Nuys and Tarzana, serving Los Angeles and the San Fernando Valley. Call before traveling to confirm the appropriate site for consultation, imaging review, procedure, or follow-up. Services and insurance-network participation can vary by location and plan.
GAE near you:GAE is billed as an outpatient embolization procedure. Original Medicare and most PPO plans are accepted and prior authorization is handled by the office; HMO, Kaiser and Medi-Cal plans generally require a referral the practice cannot initiate. Read the full GAE cost and insurance guide for coverage questions, prior authorization and self-pay estimates.
Medical content reviewed by Nathanael Sabbah, MD, interventional radiologist. Last reviewed: October 2026.